Year |
Citation |
Score |
1998 |
Mosher JT, Birkemo LS, Johnson MF, Ervin GN. Sulfated cholecystokinin (26-33) induces mild taste aversion conditioning in rats when administered by three different routes. Peptides. 19: 849-57. PMID 9663450 DOI: 10.1016/S0196-9781(98)00025-4 |
0.376 |
|
1996 |
Aquino CJ, Armour DR, Berman JM, Birkemo LS, Carr RA, Croom DK, Dezube M, Dougherty RW, Ervin GN, Grizzle MK, Head JE, Hirst GC, James MK, Johnson MF, Miller LJ, et al. Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger". Journal of Medicinal Chemistry. 39: 562-9. PMID 8558528 DOI: 10.1021/jm950626d |
0.319 |
|
1993 |
Koegler-Muly SM, Owens MJ, Ervin GN, Kilts CD, Nemeroff CB. Potential corticotropin-releasing factor pathways in the rat brain as determined by bilateral electrolytic lesions of the central amygdaloid nucleus and the paraventricular nucleus of the hypothalamus. Journal of Neuroendocrinology. 5: 95-8. PMID 8485547 DOI: 10.1111/J.1365-2826.1993.Tb00367.X |
0.495 |
|
1988 |
Ervin GN, Nemeroff CB. Antagonization of the behavioral activation produced by direct stimulation of forebrain dopamine receptors caused by intraaccumbens injections of neurotensin. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 1: 243-50. PMID 3150806 DOI: 10.1016/0893-133X(88)90024-3 |
0.521 |
|
1988 |
Ervin GN, Nemeroff CB. Interactions of neurotensin with dopamine-containing neurons in the central nervous system. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12: S53-69. PMID 3074341 DOI: 10.1016/0278-5846(88)90073-5 |
0.428 |
|
1988 |
Ervin GN, Nemeroff CB. Intra-accumbens injection of neurotensin antagonizes the behavioral supersensitivity to L-DOPA in dopamine-denervated rats Annals of the New York Academy of Sciences. 537: 496-497. DOI: 10.1111/J.1749-6632.1988.TB42137.X |
0.466 |
|
1981 |
Ervin GN, Birkemo LS, Nemeroff CB, Prange AJ. Neurotensin blocks certain amphetamine-induced behaviours. Nature. 291: 73-6. PMID 7231526 DOI: 10.1038/291073a0 |
0.548 |
|
1981 |
Ervin GN, Schmitz SA, Nemeroff CB, Prange AJ. Thyrotropin-releasing hormone and amphetamine produce different patterns of behavioral excitation in rats. European Journal of Pharmacology. 72: 35-43. PMID 6790295 DOI: 10.1016/0014-2999(81)90294-6 |
0.521 |
|
1979 |
Nemeroff CB, Osbahr AJ, Manberg PJ, Ervin GN, Prange AJ. Alterations in nociception and body temperature after intracisternal administration of neurotensin, beta-endorphin, other endogenous peptides, and morphine. Proceedings of the National Academy of Sciences of the United States of America. 76: 5368-71. PMID 291952 DOI: 10.1073/pnas.76.10.5368 |
0.428 |
|
1978 |
Kornblith CL, Ervin GN, King RA. Hypothalamic and locus coeruleus self-stimulation are decreased by cholecystokinin. Physiology & Behavior. 21: 1037-41. PMID 552067 DOI: 10.1016/0031-9384(78)90183-X |
0.332 |
|
1977 |
Nemeroff CB, Grant LD, Bissette G, Ervin GN, Harrell LE, Prange AJ. Growth, endocrinological and behavioral deficits after monosodium L-glutamate in the neonatal rat: possible involvement of arcuate dopamine neuron damage. Psychoneuroendocrinology. 2: 179-96. PMID 601168 DOI: 10.1016/0049-3848(77)90050-0 |
0.487 |
|
1977 |
Ervin GN, Fink JS, Young RC, Smith GP. Different behavioral responses to L-DOPA after anterolateral or posterolateral hypothalamic injections of 6-hydroxydopamine. Brain Research. 132: 507-20. PMID 303138 DOI: 10.1016/0006-8993(77)90198-6 |
0.323 |
|
1976 |
Young RC, Ervin GN, Smith GP. Abnormal open field behavior after anterolateral hypothalamic injection of 6-hydroxydopamine. Pharmacology, Biochemistry, and Behavior. 5: 565-70. PMID 1019187 DOI: 10.1016/0091-3057(76)90270-7 |
0.342 |
|
1975 |
Smith GP, Levin BE, Ervin GN. Loss of active avoidance of responding after lateral hypothalamic injections of 6-hydroxydopamine. Brain Research. 88: 483-98. PMID 1139290 DOI: 10.1016/0006-8993(75)90659-9 |
0.324 |
|
Show low-probability matches. |